Sanbo Neurology Co. Ltd. (301293.SZ) announced that its wholly-owned subsidiary, Sanbo Health Medical Management (Chongqing) Co., Ltd. (also known as Chongqing Sanbo Management), signed an equity transfer agreement with Honghai No.1 Investment Partnership Enterprise (Limited Partnership) (also known as Honghai No.1) on June 13, 2024 for Luoyang Wuyi 113 Sanbo Neurology Hospital Co., Ltd. The agreement stipulates that Chongqing Sanbo Management acquires 34% equity of Luoyang Sanbo owned by Honghai No.1 for a price of 51.6426 million yuan. Chongqing Sanbo Management has already paid the equity consideration.

After completion of the transaction, Chongqing Sanbo Management will hold 70% equity of Luoyang Sanbo, and Honghai No.1 will no longer hold any equity of Luoyang Sanbo. The transaction expands the company's proportion of equity held in Luoyang Sanbo and consolidates its controlling position over Luoyang Sanbo.